EZH2 and Hepatic fibrosis: EZH2 was shown to promote differentiation of fibroblasts to myofibroblasts in idiopathic pulmonary fibrosis [19] and inhibition of EZH2 reduced fibrosis-related gene expression in atrial fibrosis [20], liver fibrosis [21], and systemic sclerosis [22].